Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 379

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival

Humbert, Marc, Yaici, Azzedine, de Groote, Pascal, Montani, David, Sitbon, Olivier, Launay, David, Gressin, Virginie, Guillevin, Loïc, Clerson, Pierre, Simonneau, Gérald, Hachulla, Eric·2011·Arthritis & Rheumatism

Abstract

Objective: Pulmonary arterial hypertension (PAH) is a severe, life‐limiting complication of systemic sclerosis (SSc). Guidelines recommend early detection and management of SSc‐PAH. However, little is known about the impact of detection programs on patients with SSc‐PAH. This study was undertaken to assess the clinical characteristics of patients with SSc‐PAH at diagnosis and their long‐term outcomes. Methods: Two incident cohorts of patients with SSc‐PAH from the same management era (2002/2003) were studied. The first cohort (designated the routine practice cohort) included consecutive adult patients with symptomatic SSc in whom a diagnosis of PAH was made by right‐sided heart catheterization (RHC) at the time of recruitment into the French PAH Registry. The second cohort (designated the detection cohort) comprised consecutive patients with SSc who entered a systematic PAH detection program and were subsequently found to have PAH on RHC. Clinical characteristics at diagnosis of PAH and subsequent 8‐year mortality were compared between the cohorts. Results: There were 16 patients in each cohort. At the time of PAH diagnosis, patients in the detection cohort had less advanced pulmonary vascular disease compared with patients in the routine practice cohort, as evidenced by more patients being in New York Heart Association class I and class II, a lower mean pulmonary artery pressure and pulmonary vascular resistance index, and a higher cardiac output. Patients in the detection cohort were less likely to receive diuretics and warfarin, but there was no difference in exposure to PAH‐specific therapies between the cohorts. The 1‐, 3‐, 5‐, and 8‐year survival rates were 75%, 31%, 25%, and 17%, respectively, in the routine practice cohort compared with 100%, 81%, 73%, and 64%, respectively, in the detection cohort ( P = 0.0037). Conclusion: Compared with patients in routine clinical practice, PAH detection programs in SSc are able to identify patients with milder forms of the disease, allowing earlier management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.30541

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 379

Metadata

Authors
Humbert, M., Yaici, A., de Groote, P., Montani, D., Sitbon, O., Launay, D., Gressin, V., Guillevin, L., Clerson, P., Simonneau, G., & Hachulla, E.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2011-10-28
Volume
63
Issue
11
Pages
3522-3530
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2070897020
Cited by
379
References
25
FWCI
16.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival. https://app.cochat.ai/papers/10.1002/art.30541
The paper
Humbert, M., Yaici, A., de Groote, P., Montani, D., Sitbon, O., Launay, D., Gressin, V., Guillevin, L., Clerson, P., Simonneau, G., & Hachulla, E. (2011). Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival. Arthritis & Rheumatism. https://doi.org/10.1002/art.30541

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.